Search Results - Larry Rubinstein

Refine Results
  1. 1
    Malignant disease appearing late after operation for T1 N0 non-small-cell lung cancer

    Malignant disease appearing late after operation for T1 N0 non-small-cell lung cancer by Paul Thomas, Larry Rubinstein

    Published 1993
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer

    Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer by Robert J. Ginsberg, Larry Rubinstein

    Published 1995
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    CREATE-X a role for capecitabine in early-stage breast cancer: an analysis of available data

    CREATE-X a role for capecitabine in early-stage breast cancer: an analysis of available data by Jo Anne Zujewski, Larry Rubinstein

    Published 2017
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    The Challenge for Development of Valuable Immuno-oncology Biomarkers

    The Challenge for Development of Valuable Immuno-oncology Biomarkers by Janice M. Mehnert, Arta M. Monjazeb, Johanna M.T. Beerthuijzen, Deborah Collyar, Larry Rubinstein, Lyndsay N. Harris

    Published 2017
    Get full text Get full text
    Editorial
    Save to List
    Saved in:
  5. 5
    Validation of novel imaging methodologies for use as cancer clinical trial end-points

    Validation of novel imaging methodologies for use as cancer clinical trial end-points by Daniel J. Sargent, Larry Rubinstein, Lawrence H. Schwartz, Janet Dancey, Constantine Gatsonis, Lori E. Dodd, Lalitha Shankar

    Published 2008
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Preclinical Modeling of a Phase 0 Clinical Trial: Qualification of a Pharmacodynamic Assay of Poly (ADP-Ribose) Polymerase in Tumor Biopsies of Mouse Xenografts

    Preclinical Modeling of a Phase 0 Clinical Trial: Qualification of a Pharmacodynamic Assay of Poly (ADP-Ribose) Polymerase in Tumor Biopsies of Mouse Xenografts by Robert J. Kinders, Melinda G. Hollingshead, Sonny Khin, Larry Rubinstein, Joseph E. Tomaszewski, James H. Doroshow, Ralph E. Parchment

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Modeling Pharmacodynamic Response to the Poly(ADP-Ribose) Polymerase Inhibitor ABT-888 in Human Peripheral Blood Mononuclear Cells

    Modeling Pharmacodynamic Response to the Poly(ADP-Ribose) Polymerase Inhibitor ABT-888 in Human Peripheral Blood Mononuclear Cells by Jiuping Ji, Robert J. Kinders, Yiping Zhang, Larry Rubinstein, Shivaani Kummar, Ralph E. Parchment, Joseph E. Tomaszewski, James H. Doroshow

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Application of Molecular Profiling in Clinical Trials for Advanced Metastatic Cancers

    Application of Molecular Profiling in Clinical Trials for Advanced Metastatic Cancers by Shivaani Kummar, Paul M. Williams, Chih-Jian Lih, Eric C. Polley, A. P. Chen, Larry Rubinstein, Yongmei Zhao, Richard Simon, Barbara A. Conley, James H. Doroshow

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Biomarker-driven phase 2 study of MK-2206 and selumetinib (AZD6244, ARRY-142886) in patients with colorectal cancer

    Biomarker-driven phase 2 study of MK-2206 and selumetinib (AZD6244, ARRY-142886) in patients with colorectal cancer by T. Khanh, Giovanna Speranza, Rachel Bishop, Sonny Khin, Larry Rubinstein, Robert J. Kinders, Manuel B. Datiles, Michelle Eugeni, Michael Lam, L. Austin Doyle, James H. Doroshow, Shivaani Kummar

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials

    Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials by J I Johnson, Shannon Decker, Daniel Zaharevitz, Larry Rubinstein, John M. Venditti, Saul A. Schepartz, Sivaram Kalyandrug, Michaele C. Christian, Susan G. Arbuck, Melinda G. Hollingshead, Edward A. Sausville

    Published 2001
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Monitoring Drug-Induced γH2AX as a Pharmacodynamic Biomarker in Individual Circulating Tumor Cells

    Monitoring Drug-Induced γH2AX as a Pharmacodynamic Biomarker in Individual Circulating Tumor Cells by Lihua H. Wang, Thomas D. Pfister, Ralph E. Parchment, Shivaani Kummar, Larry Rubinstein, Yvonne A. Evrard, Martin Gutierrez, Anthony J. Murgo, Joseph E. Tomaszewski, James H. Doroshow, Robert J. Kinders

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Development of a Validated Immunofluorescence Assay for γH2AX as a Pharmacodynamic Marker of Topoisomerase I Inhibitor Activity

    Development of a Validated Immunofluorescence Assay for γH2AX as a Pharmacodynamic Marker of Topoisomerase I Inhibitor Activity by Robert J. Kinders, Melinda G. Hollingshead, Scott M. Lawrence, Jiuping Ji, Brian Tabb, William M. Bonner, Yves Pommier, Larry Rubinstein, Yvonne A. Evrard, Ralph E. Parchment, Joseph E. Tomaszewski, James H. Doroshow

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    What Can Be Done to Improve Research Biopsy Quality in Oncology Clinical Trials?

    What Can Be Done to Improve Research Biopsy Quality in Oncology Clinical Trials? by Katherine V. Ferry-Galow, Vivekananda Datta, Hala R. Makhlouf, James R. Wright, Bradford J. Wood, Elliot Levy, Etta D. Pisano, Alda L. Tam, Susanna I. Lee, Umar Mahmood, Larry Rubinstein, James H. Doroshow, Alice P. Chen

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Modern thirty-day operative mortality for surgical resections in lung cancer

    Modern thirty-day operative mortality for surgical resections in lung cancer by Robert J. Ginsberg, Lucius D. Hill, Robert T. Eagan, Paul Thomas, Clifton F. Mountain, Jean Deslauriers, Willard A. Fry, Ralph O. Butz, Melvyn Goldberg, Paul F. Waters, Donald P. Jones, Peter C. Pairolero, Larry Rubinstein, F. Griffith Pearson

    Published 1983
    Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Stage 2 Combination Testing of Rapamycin with Cytotoxic Agents by the Pediatric Preclinical Testing Program

    Stage 2 Combination Testing of Rapamycin with Cytotoxic Agents by the Pediatric Preclinical Testing Program by Peter J. Houghton, Christopher L. Morton, Richard Görlick, Richard B. Lock, Hernán Carol, C. Patrick Reynolds, Min H. Kang, John M. Maris, Stephen T. Keir, E. Anders Kolb, Jianrong Wu, Amy Wozniak, Catherine A. Billups, Larry Rubinstein, Malcolm A. Smith

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    First-in-human study of the epichaperome inhibitor PU-H71: clinical results and metabolic profile

    First-in-human study of the epichaperome inhibitor PU-H71: clinical results and metabolic profile by Giovanna Speranza, Larry Anderson, Alice P. Chen, T. Khanh, Michelle Eugeni, Marcie Weil, Larry Rubinstein, Eva Majerová, Jerry M. Collins, Yvonne Horneffer, Lamin Juwara, Jennifer Zlott, Rachel Bishop, Barbara A. Conley, Howard Streicher, Joseph E. Tomaszewski, James H. Doroshow, Shivaani Kummar

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    National Cancer Institute Breast Cancer Steering Committee Working Group Report on Meaningful and Appropriate End Points for Clinical Trials in Metastatic Breast Cancer

    National Cancer Institute Breast Cancer Steering Committee Working Group Report on Meaningful and Appropriate End Points for Clinical Trials in Metastatic Breast Cancer by Andrew D. Seidman, Louise Bordeleau, Louis Fehrenbacher, William E. Barlow, Jane Perlmutter, Larry Rubinstein, Suparna Wedam, Dawn L. Hershman, Jennifer Fallas Hayes, Lynn Pearson Butler, Mary Lou Smith, Meredith M. Regan, Julia A. Beaver, Laleh Amiri‐Kordestani, Priya Rastogi, Jo Anne Zujewski, Larissa A. Korde

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Analytical Validation and Application of a Targeted Next-Generation Sequencing Mutation-Detection Assay for Use in Treatment Assignment in the NCI-MPACT Trial

    Analytical Validation and Application of a Targeted Next-Generation Sequencing Mutation-Detection Assay for Use in Treatment Assignment in the NCI-MPACT Trial by Chih-Jian Lih, David Sims, Robin Harrington, Eric C. Polley, Yingdong Zhao, Michele G. Mehaffey, Thomas Forbes, Biswajit Das, William D. Walsh, Vivekananda Datta, Kneshay N. Harper, Courtney H. Bouk, Larry Rubinstein, Richard Simon, Barbara A. Conley, Alice P. Chen, Shivaani Kummar, James H. Doroshow, P. Mickey Williams

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    A Phase I Study of Veliparib in Combination with Metronomic Cyclophosphamide in Adults with Refractory Solid Tumors and Lymphomas

    A Phase I Study of Veliparib in Combination with Metronomic Cyclophosphamide in Adults with Refractory Solid Tumors and Lymphomas by Shivaani Kummar, Jiuping Ji, Robert J. Morgan, Heinz-Josef Lenz, Shannon L. Puhalla, Chandra P. Belani, David R. Gandara, Deborah Allen, Brian F. Kiesel, Jan H. Beumer, Edward M. Newman, Larry Rubinstein, Alice P. Chen, Yiping Zhang, Lihua Wang, Robert J. Kinders, Ralph E. Parchment, Joseph E. Tomaszewski, James H. Doroshow

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Phase I Study of PARP Inhibitor ABT-888 in Combination with Topotecan in Adults with Refractory Solid Tumors and Lymphomas

    Phase I Study of PARP Inhibitor ABT-888 in Combination with Topotecan in Adults with Refractory Solid Tumors and Lymphomas by Shivaani Kummar, Alice P. Chen, Jiuping Ji, Yiping Zhang, Joel M. Reid, Matthew M. Ames, Lee Jia, Marcie Weil, Giovanna Speranza, Anthony J. Murgo, Robert J. Kinders, Lihua Wang, Ralph E. Parchment, John Carter, Howard Stotler, Larry Rubinstein, Melinda G. Hollingshead, Giovanni Melillo, Yves Pommier, William Bonner, Joseph E. Tomaszewski, James H. Doroshow

    Published 2011
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: